A multicenter study of the real-world effectiveness and safety of risankizumab in Crohn’s disease
In this large multicenter cohort of patients with CD, RZB was well-tolerated and effective in achieving favorable clinical and endoscopic outcomes in both AT-exposed and naïve populations, including those with exposure to UST.
Authors
- David Dulaney (ORCID: https://orcid.org/0000-0001-9796-9982)
- Amanda M. Johnson (ORCID: https://orcid.org/0000-0003-2838-0538)
- Abdul Wali Khan (ORCID: https://orcid.org/0000-0002-5450-930X)
- Parakkal Deepak (ORCID: https://orcid.org/0000-0002-3436-9784)
- Marc Fenster
- Neha Seth (ORCID: https://orcid.org/0000-0002-3299-4201)
- Anthony Xu (ORCID: https://orcid.org/0000-0001-9330-2582)
- Ryan C. Ungaro (ORCID: https://orcid.org/0000-0001-8687-3758)
- Andrés Yarur (ORCID: https://orcid.org/0000-0003-2293-5555)
- Shrinivas Bishu (ORCID: https://orcid.org/0000-0003-4823-5805)
- Jalpa Devi (ORCID: https://orcid.org/0000-0001-8710-2381)
- Edward V. Loftus (ORCID: https://orcid.org/0000-0001-7199-6851)
- Fnu Jaiprada
- Manar Askar
- Seema Belani
- Blake Kassmeyer
- Anish Patel (ORCID: https://orcid.org/0000-0002-1880-7991)
- Katherine Huang (ORCID: https://orcid.org/0000-0002-5013-4790)
- Hyder Said (ORCID: https://orcid.org/0000-0002-9022-9487)
- Michael Santiago-Castro
Institutions
- Cedars-Sinai Medical Center (US)
- Brooke Army Medical Center (US)
- Montefiore Medical Center (US)
- Baylor College of Medicine (US)
- Washington University in St. Louis (US)
- University of Michigan (US)
- Wilford Hall Ambulatory Surgical Center (US)
- Michigan Medicine (US)
- Mayo Clinic in Arizona (US)
- Icahn School of Medicine at Mount Sinai (US)
Publication Details
- Journal
- Journal of Crohn s and Colitis
- Published
- 2025-04-18
- DOI
- https://doi.org/10.1093/ecco-jcc/jjaf070
- Citations
- 8
- Primary Topic
- Inflammatory Bowel Disease
- Type
- article
- Field-Weighted Citation Impact
- 14.54